Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sales Of Drug-Spiked Supplements After Warnings Show Stronger US Regulation Needed – Study

Jul 27 2022

• By Hannah Daniel

• Source: Shutterstock

Related Content

Final Conviction In US FDA's Spiked-Supplement Investigation Of Blackstone Labs

Mar 17 2022

Senate FDA User Fee Bill’s Mandatory Supplement Listing Provision Unites Industry In Opposition

Jun 16 2022

With Mandatory Product Listing, FDA Not Looking For Gate To Open Or Close On Supplements

Jul 22 2022

Congress Should Open CBD Door, Close VMS Market Holes – Sharfstein, Cohen

Jun 14 2019

GMPs, DMHA Spell FDA Warning For Revital U International

Nov 13 2019

Additional Topics

United States Warning Letters Research & Development FDA Commercial Companies Compliance Dietary Supplements Enforcement Ingredients Recalls Consumer

More from Compliance

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window